Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870101 · ClinicalTrials.gov registry record · NA
Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT
A NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 2,767
- Enrollment target
- 9
- Study locations
NCT02870101: Completed NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection, sponsored by Duke University.
NCT02870101 is a NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection that has completed, run by Duke University. The registered enrollment target is 2,767 participants, above the 631-participant average among 10 other Sexually Transmitted Infections trials with a reported enrollment target (339% higher). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02870101, a NA study of Sexually Transmitted Infections and Neisseria Gonorrhoeae Infection, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,767 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.
Primary Outcome
NAAT 1 index test results include negative, positive, and no result. ASIS reference results are the combination of the NAAT 2 and NAAT 3 index test results. ASIS reference results include negative, positive, indeterminate, and invalid.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Nucleic acid amplification test 1 for NG and CT
- DIAGNOSTIC_TEST Nucleic acid amplification test 2 for NG and CT
- DIAGNOSTIC_TEST Nucleic acid amplification test 3 for NG and CT
Study Locations (9)
California
- AIDS Health Foundation - Hollywood - Hollywood
- Los Angeles LGBT Clinic - Los Angeles
Florida
- AIDS Healthcare Foundation - Miami - Miami
- University of Miami - Miami
Colorado
- Denver Health and Hospital Authority - Denver
Louisiana
- Louisiana State University - New Orleans
Michigan
- Wayne State University - Detroit
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- Central Texas Clinical Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,767 participants |
| Start Date | 2017-04-10 |
| Est. Completion | 2018-03-12 |
| Phase | NA |
What the finished NCT02870101 record still lists
NCT02870101 is an interventional study that assigns participants to a tested intervention. Its 2,767 participants enrollment target places it among the larger protocols in the corpus, above the 631-participant average among 10 other Sexually Transmitted Infections trials with a reported enrollment target (339% higher).
The record links to 3 conditions, with Sexually Transmitted Infections appearing as the primary indexed condition, and to 3 interventions - of which Nucleic acid amplification test 1 for NG and CT is the first listed.
NCT02870101 lists 9 locations in 7 states (California, Florida, Colorado).
Frequently Asked Questions
What is clinical trial NCT02870101 about?
NCT02870101 is a clinical study titled "Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT". The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.
What is the current status of trial NCT02870101?
This trial is currently completed. It is a NA study. The enrollment target is 2,767 participants. The study started on 2017-04-10. Estimated completion is 2018-03-12.
What conditions does trial NCT02870101 study?
This clinical trial studies the following conditions: Sexually Transmitted Infections, Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection.
What interventions are being tested in trial NCT02870101?
The interventions under investigation include: Nucleic acid amplification test 1 for NG and CT (DIAGNOSTIC_TEST), Nucleic acid amplification test 2 for NG and CT (DIAGNOSTIC_TEST), Nucleic acid amplification test 3 for NG and CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02870101?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02870101 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02870101's enrollment target sits among peer trials
2,767 1st of 10 higher than 10 of 10 other Sexually Transmitted Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexually Transmitted Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gathering Online for Dialogue and Discussion to Enhance Social Support
RECRUITING · NA
-
Evaluation of the SafeSpace App Intervention
RECRUITING · NA
-
Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
HIV Prevention Program for African American Teen Males
COMPLETED · NA
-
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI